Advertisement

Clinical Journal of Gastroenterology

, Volume 11, Issue 6, pp 457–460 | Cite as

Novel variant of unknown significance in MUTYH in a patient with MUTYH-associated polyposis: a case to reclassify

  • Trilokesh D. Kidambi
  • Dena Goldberg
  • Robert Nussbaum
  • Amie Blanco
  • Sarah E. Umetsu
  • Jonathan P. Terdiman
  • Jeffrey K. Lee
Case Report
  • 67 Downloads

Abstract

MUTYH-associated polyposis (MAP) is a hereditary cancer syndrome that is caused by biallelic pathogenic variants in the MUTYH gene and should be evaluated for in patients with an attenuated colonic polyposis phenotype. Monoallelic pathogenic variants in MUTYH are associated with a moderate increased risk of colorectal cancer but not with the polyposis phenotype. We present a case of a patient presenting with multiple colonic adenomatous polyps, whose germline testing revealed a heterozygous pathogenic variant in MUTYH in exon 13, c.1187G > A (p.Gly396Asp) as well as a heterozygous variant of unknown significance (VUS) in MUTYH in exon 14, c.1379T > C (p.Leu460Ser). We interpret the VUS as pathogenic in light of the patient’s phenotype; the fact that the VUS was in trans with a known pathogenic variant; and because all the in silico predictors suggested, it was likely to be deleterious. This case highlights the importance of a gastroenterologist recognizing the indication for genetic testing in a patient with greater than ten adenomas, the importance of a genetic counselor in interpretation of results, and is the first report of the specific variant in the literature with clinical information to suggest that it is likely pathogenic.

Keywords

MUTYH MYH-associated polyposis Hereditary cancer syndrome Polyposis Multiple colorectal adenomas 

Notes

Acknowledgements

National Cancer Institute (K07CA212057) and American Gastroenterological Association grant both awarded to JKL.

Compliance with ethical standards

Conflict of interest

Trilokesh Kidambi, Dena Goldberg, Jonathan Terdiman, Sarah Umetsu and Jeffrey Lee declare they have no conflict of interest. Robert Nussbaum is the chief medical officer at Invitae Corp. Amie Blanco’s spouse is a paid employee of Genentech.

Human/animal rights

All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

Informed consent

Informed consent was obtained from all patients for being included in the study.

Supplementary material

12328_2018_870_MOESM1_ESM.docx (14 kb)
Supplementary material 1 (DOCX 13 KB)

References

  1. 1.
    Hegde M, Ferber M, Mao R, et al. Acmg technical standards and guidelines for genetic testing for inherited colorectal cancer (lynch syndrome, familial adenomatous polyposis, and myh-associated polyposis). Genet Med. 2014;1:101–16.CrossRefGoogle Scholar
  2. 2.
    Kastrinos F, Syngal S. Inherited colorectal cancer syndromes. Cancer J. 2011;17:405–15.CrossRefGoogle Scholar
  3. 3.
    Goodenberger M, Lindor NM. Lynch syndrome and myh-associated polyposis: review and testing strategy. J Clin Gastroenterol. 2011;45:488–500.CrossRefGoogle Scholar
  4. 4.
    Sieber OM, Lipton L, Crabtree M, et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in myh. N Engl J Med. 2003;348:791–9.CrossRefGoogle Scholar
  5. 5.
    Wang L, Baudhuin LM, Boardman LA, et al. Myh mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps. Gastroenterology. 2004;127:9–16.CrossRefGoogle Scholar
  6. 6.
    Grover S, Kastrinos F, Steyerberg EW, et al. Prevalence and phenotypes of apc and mutyh mutations in patients with multiple colorectal adenomas. JAMA. 2012;308:485–92.CrossRefGoogle Scholar
  7. 7.
    LaDuca H, Stuenkel AJ, Dolinsky JS, et al. Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients. Genet Med. 2014;16:830–7.CrossRefGoogle Scholar
  8. 8.
    Nielsen M, Lynch H, Infante E, Brand R. Mutyh-associated polyposis. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle, WA: University of Washington; 1993.Google Scholar
  9. 9.
    Ruggieri V, Pin E, Russo MT, et al. Loss of mutyh function in human cells leads to accumulation of oxidative damage and genetic instability. Oncogene. 2013;32:4500–8.CrossRefGoogle Scholar
  10. 10.
    Morak M, Laner A, Bacher U, et al. Mutyh-associated polyposis - variability of the clinical phenotype in patients with biallelic and monoallelic mutyh mutations and report on novel mutations. Clin Genet. 2010;78:353–63.CrossRefGoogle Scholar

Copyright information

© Japanese Society of Gastroenterology 2018

Authors and Affiliations

  1. 1.Division of GastroenterologyUniversity of California, San FranciscoSan FranciscoUSA
  2. 2.Hereditary GI Cancer Prevention Program, Helen Diller Family Comprehensive Cancer CenterUniversity of California, San FranciscoSan FranciscoUSA
  3. 3.Invitae CorporationSan FranciscoUSA
  4. 4.Department of PathologyUniversity of California, San FranciscoSan FranciscoUSA
  5. 5.Department of GastroenterologyKaiser Permanente Northern CaliforniaSan FranciscoUSA

Personalised recommendations